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Summary Background: Continuous positive airway pressure (CPAP) remains the
treatment of choice for obstructive sleep apnea–hypopnea (OSAH). Auto-titrating
CPAP (APAP) devices automatically adjust pressure and may improve treatment
compliance compared to fixed CPAP (F-CPAP).
Methods: Randomized, prospective, single-blind, crossover trial to compare
efficacy, side effects, compliance, patient satisfaction and preference between
APAP and F-CPAP therapy in patients with moderate to severe OSAH. There were two
treatment periods of 4 weeks each (APAP and F-CPAP), separated by a 2-week
washout period.
Results: Ten CPAP-na.ıve OSAH patients (9 males) completed the study. They had
Mean7 SD age of 44.979.7 years; body mass index of 35.9712.9 kg/m2 and apnea/
hypopnea index (AHI) of 47.2735.6. Both forms of therapy were equally effective in
improving the symptoms and in reducing the AHI. Both forms of therapy were
associated with frequent side effects and had similar patient compliance. At the end
of the study, more patients (6–1) preferred F-CPAP to A-CPAP therapy.
Conclusion: A-PAP was as effective as F-CPAP in the treatment of OSAH but was not
associated with fewer side effects, better compliance, better satisfaction or
increased patient preference.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Nasal continuous positive airway pressure (CPAP)
remains treatment of choice for obstructive sleep
apnea–hypopnea (OSAH).1 Fixed CPAP (F-CPAP)
machines deliver a constant pressure that may be
excessive during times of the night. Auto-titrating
CPAP (APAP) devices automatically adjust the level
of positive pressure according to patient’s needs.2
Preliminary studies have shown that APAP is as
effective as F-CPAP but the evidence that it
increases compliance to CPAP therapy is contro-
versial.3 The aim of this randomized trial was to
compare the efficacy, side effects, patient com-
pliance, satisfaction and preference between APAP
and F-CPAP in treatment of OSAH.
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Methods
Ten CPAP-na.ıve patients (9 males) with sympto-
matic OSAH (apnea/hypopnea index (AHI) 415/h)
were recruited for this randomized prospective
single-blind crossover trial. An initial overnight,
supervised polysomnogram was conducted and
scored according to previously described method.4
A second night CPAP-titration study was performed
to determine effective pressure. Patients were
randomized to receive APAP and F-CPAP for 4 weeks
each separated by a 2-week washout period.
Patients were unaware of the treatment mode
and referred to the two treatment periods as
treatment A and treatment B. At the end of each
treatment period and the washout period, ques-
tionnaire was administered and home sleep mon-
itoring was performed. Questionnaire elicited
information about symptoms, treatment efficacy,
side effects, and patient satisfaction, and Epworth
sleepiness scale. At the end of the study, each
patient was asked whether they would prefer to use
the first or the second form of CPAP therapy. Home
sleep monitoring was performed with the Poly-G
Portable Apnea Recorder and Sleep I/T-8 (CNS Inc,
Chanhassen, Minnesota, USA).
CPAP therapy was undertaken with a Virtuosos
smart CPAP system (Respironics Inc, Murrysville,
Pennsylvania, USA). For each patient, the same
machine was used either in F-CPAP (pressure equal
to determined titration pressure) or in APAP
(pressure range 3–20 cm H2O) mode. The APAP
system utilized an algorithm that used a pressure
transducer and microprocessor to monitor the
airway for vibration patterns. When three airway
instability events were detected within 1min, the
pressure increased by 2 cm H2O over a 1-min
period. When no events indicating instability were
detected, the pressure decreased by 1 cm H2O over
a 5-min period. The built-in time meter within the
CPAP system monitored total machine usage and
cumulative patient compliance (time at pressure)
and was used to evaluate treatment compliance.
Paired t-test was used to compare the results of
two treatment periods (APAP and CPAP). Statistical
significance of differences for repeated observa-
tions was tested with repeated measures analysis of
variance (ANOVA). All P values o0.05 were con-
sidered significant.
Results
Patients reported symptoms of snoring (100%),
witnessed apnea (80%), unrefreshing sleep (80%)
and excessive daytime sleepiness (70%). The mean
7 SD age was 44.979.7 years, body mass index
(BMI) of 35.9712.9 kg/m2 and neck circumference
45.074.0 cm. Table 1 summarizes Epworth sleepi-
ness scale score and sleep study values at baseline
and after each mode of therapy (APAP and F-CPAP).
Both forms of therapy were highly effective in
improving snoring, excessive daytime sleepiness,
AHI, arousal index and desaturation index. During
APAP therapy, patients required lower pressure
(6.774.1) than F-CPAP therapy (11.771.7) cm of
H2O (P¼ 0.001) but the minimum arterial oxygen
saturation (SaO2) was lower during APAP therapy
(P¼ 0.03).
Objective monitoring showed similar compliance
with APAP (4.371.9) and F-CPAP therapy
(3.772.6) h/night (P¼NS). Patients reported simi-
lar compliance, satisfaction with therapy and
difficulty in using the machine with both forms of
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Table 1 Home sleep monitoring data and Epworth sleepiness scale score at baseline and after each mode of
CPAP therapy.
Baseline APAP F-CPAP
Apnea/hypopnea index 47.2735.6n 13.178.3 9.675.4
Arousal index 17.3717.7n 5.976.5 4.973.7
Desaturation index 53.0736.0n 15.0714 10.0713
Minimum O2 saturation 67.8712.5
n 81.876.2nn 85.773.8nn
Basal O2 saturation 91.374.5
n 94.671.0 95.37 1.6
Total sleep time (min) 381792 346787 3607108
Stage 1–2 sleep (%) 71727 7179 62719
Stage 3–4 sleep (%) 14725 1077 18719
REM sleep (%) 1577 1976 2076
Epworth score 11.176.4n 8.075.7 6.675.9
Values expressed as mean7SD.
nDenotes Po0.05, between baseline and after either form of therapy.
nnDenotes Po0.05, between APAP and F-CPAP therapy.
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therapy. Nearly half of the patients who had
difficulty in using one mode of therapy were
able to tolerate the other mode. At the end of
the trial, more patients preferred F-CPAP than
A-CPAP (60% vs. 10%; P ¼ 0:06), with 10% satisfied
with either and 20% satisfied with neither of the
two treatments.
Discussion
Our study confirmed that APAP was an effective
therapy for treatment of OSAH and required
significantly lower airway pressure than F-CPAP
therapy. Both forms of therapy were associated
with frequent minor side effects. Nearly half of the
patients who had difficulty in using one CPAP mode
were able to tolerate the other mode with minimal
discomfort. APAP therapy did not lead to better
treatment compliance. Our study was limited by
small sample size and some of the differences
observed between the two treatment groups,
though clinically important, may not reach statis-
tical significance.
There have been few randomized trials compar-
ing APAP and F-CPAP therapy for a period of week or
more. Two had shown an improved compliance with
APAP therapy3,5 whereas four trials reported
compliance similar to F-CPAP.6–9 In addition, there
are safety concerns with the use of APAP therapy
that need further study. Despite an adequate
control of AHI, significant arterial oxygen desatura-
tion can still occur. The minimum arterial SaO2 was
lower with APAP therapy in our study. D’Ortho
et al.7 found that patients on APAP spent
8.8720.5min with SaO2 less than 90% compared
to 3.6710.3min on F-CPAP therapy. In a single
night study of 20 patients using a Respironics
prototype, Sharma et al. found that the minimum
arterial SaO2 was significantly lower with APAP than
F-CPAP.10 Scharf et al.11 using a DeVilbiss NCPAP 3
system (Horizon auto adjust) reported a slight
increase in frequency of hypopnea events during
use of APAP system. Central apnea may occur
during APAP treatment. The American Academy of
Sleep Medicine recommends that patients with
congestive heart failure, chronic lung diseases,
patients expected to have nocturnal desaturation
for reasons other than OSAH (e.g. obesity hypo-
ventilation syndrome) and patients who do not
snore (either due to surgery or naturally) are not
currently candidates for APAP titration or treat-
ment.12
A number of APAP devices are commercially
available. They monitor different parameters to
detect breathing events and utilize a variety of
algorithms to adjust the pressure. There is no clear
evidence that one APAP technology is superior to
the other and results from study of one device
cannot be generalized to all APAP devices. A recent
bench study compared the responses of five
commonly used APAP machines, including the one
used in this trial, to well-defined breathing pat-
terns.13 In response to a pattern of repetitive
apneas two devices did not modify positive airway
pressure, two increased the pressure to 10 cm and
one to 16 cm H2O. Most of the devices failed to
increase the pressure in response to various
hypopnea patterns but all devices increased the
pressure when snoring was included in the flow
limitation pattern. The rates of automatic pressure
reduction after normalizing the breathing pattern
were also different among the five APAP devices.
In summary, CPAP is an effective therapy for
symptomatic OSAH. F-CPAP has been used exten-
sively and remains the machine of choice for long-
term home therapy. The APAP machine is neither
more effective nor more preferred by the patient.
Further studies are needed to define patient
subgroups in which APAP can be recommended as
the initial mode of therapy.
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